Third Party Participation in Early Benefit Assessment of Cancer Drugs in Germany
Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2430
https://www.valueinhealthjournal.com/article/S1098-3015(14)04360-5/fulltext
Title :
Third Party Participation in Early Benefit Assessment of Cancer Drugs in Germany
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04360-5&doi=10.1016/j.jval.2014.08.2430
First page :
A662
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1885